Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal Seizures”

245 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 245 results

Not applicableStudy completedNCT03059381
What this trial is testing

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

Who this might be right for
Partial Seizures (With or Without Secondary Generalized Seizures)Primary Generalized Tonic-clonic Seizures
Eisai Co., Ltd. 519
Not applicableStudy completedNCT00297349
What this trial is testing

The Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures

Who this might be right for
SeizuresEpilepsy
Janssen Cilag Pharmaceutica S.A.C.I., Greece 153
Post-approval studies (Phase 4)Ended earlyNCT05684978
What this trial is testing

Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus

Who this might be right for
Refractory Status Epilepticus
Wayne State University 1
Large-scale testing (Phase 3)Study completedNCT01463306
What this trial is testing

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Epilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Testing effectiveness (Phase 2)Study completedNCT02495844
What this trial is testing

UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Who this might be right for
Highly Drug-resistant Focal Epilepsy
UCB Biopharma S.P.R.L. 55
Large-scale testing (Phase 3)Study completedNCT00210782
What this trial is testing

A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment

Who this might be right for
Epilepsy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 262
Large-scale testing (Phase 3)Study completedNCT00515619
What this trial is testing

Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures

Who this might be right for
Epilepsy
UCB Pharma 376
Not applicableLooking for participantsNCT06241924
What this trial is testing

Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement

Who this might be right for
Parkinson DiseaseEpilepsy
University Hospital, Bordeaux 30
Not applicableStudy completedNCT02392078
What this trial is testing

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Who this might be right for
Metastatic Brain TumorPrimary Brain TumorEpileptic/Seizure Foci+1 more
Monteris Medical 1,153
Not applicableStudy completedNCT00044252
What this trial is testing

Role of Hormones in Susceptibility to Seizures in Women With Epilepsy

Who this might be right for
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 50
Testing effectiveness (Phase 2)Study completedNCT00236847
What this trial is testing

The Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60
Testing effectiveness (Phase 2)Study completedNCT00210652
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 47
Large-scale testing (Phase 3)Study completedNCT00596466
What this trial is testing

Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures

Who this might be right for
Epilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 75
Large-scale testing (Phase 3)Study completedNCT00620555
What this trial is testing

A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 65
Not applicableActive Not RecruitingNCT05248269
What this trial is testing

Thermocoagulation in Drug Resistant Focal Epilepsy

Who this might be right for
EpilepsySeizures, FocalEpilepsy Intractable+1 more
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia 75
Not applicableStudy completedNCT03443388
What this trial is testing

Novel Helmet Design in Patients With Seizures

Who this might be right for
Drug Resistant EpilepsyDrop SeizuresGeneralized Tonic Clonic Seizure+2 more
Michael A. Gelfand, MD, PhD 9
Not applicableStudy completedNCT00344877
What this trial is testing

Electrical Brain Stimulation to Reduce Epileptic Seizures

Who this might be right for
Temporal Lobe Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS) 56
Large-scale testing (Phase 3)Enrolling By InvitationNCT07287163
What this trial is testing

Clinical Trial of Vormatrigine in Adult Patients With Epilepsy

Who this might be right for
Epilepsy, Tonic-ClonicFocal SeizurePrimary Generalized Seizure
Praxis Precision Medicines 700
Testing effectiveness (Phase 2)Study completedNCT06377930
What this trial is testing

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Who this might be right for
Focal Onset Seizures
Rapport Therapeutics Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00044278
What this trial is testing

Pediatric Epilepsy Study in Subjects 1-24 Months

Who this might be right for
Epilepsy
GlaxoSmithKline 197
Load More Results